Oslo, 22 September 2026 - Observe Medical ASA (the "Company" or "Observe Medical") today announces the launch of its new website, designed to create a direct, responsive dialogue with healthcare decision-makers about UnoMeter™ Safeti™ Max, an innovative solution with the potential to deliver clear clinical and health-economic advantages.
The new digital platform provides healthcare leaders, decision-makers, clinicians and other stakeholders with accessible information about UnoMeter™ Safeti™ Max and the rest of the Company’s portfolio, its clinical evidence and its contribution to more efficient and sustainable healthcare.
“Healthcare decision-makers need clear, evidence-based information that demonstrates both patient value and the broader impact on healthcare systems,” said Jørgen Mann, CEO at Observe Medical. “With our new website, we want to make it easier to engage directly with those responsible for healthcare decisions and have a constructive dialogue about how UnoMeter™ Safeti™ Max can address important clinical and health-economic needs.”
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available atwww.observemedical.com.